This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA) | MicrobiomeTrials
← Back to trials NCT07269938
Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA) Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10Est. Completion: 2029-04
Enrollment target: 30 participantsLocations University of Edinburgh, Edinburgh, City Of Edinburgh, United Kingdom Other microbiome trials you might be interested in Arteritis, Giant Cell Blindness and Low Vision
Giant cell arteritis , also named Horton's disease, is the most common vasculitis in subjects over 50 years old. The inc…
Cannes, France Completed Jul 26, 2023
Takayasu's Arteritis Giant Cell Arteritis Polyarteritis Nodosa Relapsing Polychondritis ANCA-Associated Vasculitis
Background:
\- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many me…
Bethesda, United States
Est. completion Jan 1, 2050